Scientists make white blood cells to alleviate pain during tissue inflammation in mice

February 5, 2018, University of Granada
Scientists make white blood cells to alleviate pain, instead of producing it, during tissue inflammation in mice
Role of the sigma‑1 receptor in inflammatory pain. (A) Leukocytes present in the inflamed site release algogenic chemicals that contribute to pain, along with endogenous opioid peptides. Said opioid peptides do not relieve pain because the sigma‑1 receptor inhibits the functioning of opioid receptors. (B) Sigma‑1 blockers remove the brake on the functioning of opioid receptors, thus resulting in pain relief. Credit: University of Granada

Researchers at the University of Granada led a novel study in mice that shows that sigma‑1 receptor blockers cause white blood cells or leukocytes to relieve pain when a tissue is inflamed

Immune system cells (leukocytes or ) accumulate in the tissues, for example, after suffering a trauma or a wound. Their main function is repairing the damaged tissue. However, in addition to that function, those cells release substances that produce (called algogenic chemicals), playing a key role in the pain felt when the tissue is inflamed. This is also applicable to certain chronic pathologies that present inflammation and pain, as is the case of arthritis.

Paradoxically, these leukocytes, in addition to releasing algogenic chemicals, are capable of producing endogenous opioid peptides (such as endorphins). These peptides have the same activity as opioid analgesics used for treating pain. However, the balance between the analgesic and the pain‑inducing activity of leukocytes during inflammation clearly favors pain; in fact, inflammation produces pain.

The sigma‑1 receptor is a very small protein present in neurons, and is capable of modulating the action of opioid receptors. A study led by scientists from the University of Granada (UGR) has discovered that sigma‑1 receptor blockers are capable of increasing the effect of produced by , so that these cells relieve pain instead of producing it when they are in the inflamed tissue.

"We present a totally novel pain relief mechanism, based on maximizing the analgesic potential of the , and which could have important therapeutic applications in patients with pain of inflammatory origin", says the director of this work, professor Enrique J. Cobos del Moral, researcher from the Department of Pharmacology and the Institute of Neuroscience of the University of Granada.

Explore further: Opioids produce analgesia via immune cells

More information: Miguel A. Tejada et al. Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice, Proceedings of the National Academy of Sciences (2017). DOI: 10.1073/pnas.1620068114

Related Stories

Opioids produce analgesia via immune cells

January 17, 2017
Opioids are the most powerful painkillers. Researchers at the Charité - Universitätsmedizin Berlin have now found that the analgesic effects of opioids are not exclusively mediated by opioid receptors in the brain, but ...

Drug that strengthens analgesic effect of opioids without increasing constipation tested

March 28, 2014
Scientists from the University of Granada have taken part, alongside the Esteve laboratory, in the development of a new drug that multiplies the analgesic effect of opioids (drugs for treating intense pain), without increasing ...

Scientists open the door to the development of better analgesics for treating joint pain

December 19, 2017
Researchers from the University of Granada have led a novel study in mice which shows that neurons mediating joint pain are different from those mediating cutaneous pain

A new promising approach in the therapy of pain

December 4, 2012
The treatment of inflammatory pain can be improved by endogenous opioid peptides acting directly in injured tissue. Scientists at the Charité – Universitätsmedizin Berlin and the Université Paris Descartes showed that ...

Safer opioid drugs could treat pain and save lives

December 5, 2017
Opioid drugs are the most widely prescribed and effective type of pain medication. But they are highly addictive and have some unpleasant and potentially deadly side effects.

Scientists discover powerful potential pain reliever

August 16, 2017
A team of scientists led by chemists Stephen Martin and James Sahn at The University of Texas at Austin have discovered what they say is a powerful pain reliever that acts on a previously unknown pain pathway. The synthetic ...

Recommended for you

New clues to the origin and progression of multiple sclerosis

November 13, 2018
Mapping of a certain group of cells, known as oligodendrocytes, in the central nervous system of a mouse model of multiple sclerosis (MS), shows that they might have a significant role in the development of the disease. The ...

Mutations, CRISPR, and the biology behind movement disorders

November 12, 2018
Scientists at the RIKEN Center for Brain Science (CBS) in Japan have discovered how mutations related to a group of movement disorders produce their effects. Published in Proceedings of the National Academy of Sciences, the ...

Concussion tied to suicide risk

November 12, 2018
(HealthDay)—People who have experienced either a concussion or a mild traumatic brain injury are twice as likely to commit suicide than others, a new review suggests.

In live brain function, researchers are finally seeing red

November 12, 2018
For years, green has been the most reliable hue for live brain imaging, but after using a new high-throughput screening method, researchers at the John B. Pierce Laboratory and the Yale School of Medicine, together with collaborators ...

Autism is associated with zinc deficiency in early development—now a study links the two

November 9, 2018
The emergence of autism in children has not only been linked to genes encoding synaptic proteins—among others—but also environmental insults such as zinc deficiency. Although it is unclear whether zinc deficiency contributes ...

Scientists solve century-old neuroscience mystery—answers may lead to epilepsy treatment

November 9, 2018
Scientists at the Virginia Tech Carilion Research Institute have solved a 125-year-old mystery of the brain, and, in the process, uncovered a potential treatment for acquired epilepsy.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.